Hong Kong Global Pharmaceutical Pty Ltd. was established in 2011, based on a simple observation: patients with rare diseases are often told that the medications they need are simply unavailable—not because they do not exist, but because they are not approved, not in stock, or not distributed in their country.

We set out to close that gap. Over the years, we built relationships with suppliers across the US, Europe, and India, and became one of the first licensed pharmaceutical trading companies in Hong Kong to focus specifically on rare disease medicines.

Today, we continue to operate the same way we started — one patient, one inquiry, one order at a time. We're not the biggest name in the industry, but we've stayed licensed, stayed accountable, and stayed focused on the same problem we set out to solve.